早期心理健康改善与溃疡性结肠炎长期疾病缓解相关
本研究利用SELECTION试验中381例接受非戈替尼治疗的溃疡性结肠炎患者数据,评估第10周心理健康改善与第58周疾病缓解的关系。心理健康应答(子量表评分变化≥7.85)与内镜缓解(aOR 2.67)、临床缓解(aOR 1.91)、组织学缓解(aOR 1.98)及疾病清除(aOR 3.48)的更高几率显著相关。早期心理健康改善可独立预测长期疾病缓解,将心理健康评估整合入溃疡性结肠炎管理策略可能提供超越躯体症状的有价值信息。
要点
- 第10周心理健康应答(子量表评分变化≥7.85)与第58周内镜缓解aOR 2.67、临床缓解aOR 1.91、组织学缓解aOR 1.98、疾病清除aOR 3.48显著相关。
- 仅第10周达到临床缓解而未达到心理健康应答者,第58周内镜缓解几率约为同时达到两者的一半(aOR 0.45,95%CI 0.21-0.91)。
- 将心理健康应答评估与临床缓解结合可显著增强结局预测。
核心结论
- 早期心理健康改善可独立预测溃疡性结肠炎的长期疾病缓解。
- 将心理健康评估整合入溃疡性结肠炎管理策略可能提供超越躯体症状的有价值信息。
研究设计与样本
- 本研究使用SELECTION试验数据,纳入381例接受非戈替尼治疗的患者。
- 心理健康采用36项简表调查心理健康子量表评估。
- 第58周评估内镜、临床和组织学结局。
- 采用多因素logistic回归计算校正比值比(aOR)及95%置信区间(95%CI)。
- 采用受试者工作特征曲线结合bootstrap重采样确定心理健康应答阈值。
主要发现
- 第10周心理健康改善与第58周疾病缓解显著相关。
- 心理健康应答(子量表评分变化≥7.85)者达到内镜缓解的aOR为2.67(95%CI 1.43-5.25)。
- 心理健康应答者达到临床缓解的aOR为1.91(95%CI 1.22-2.99)。
- 心理健康应答者达到组织学缓解的aOR为1.98(95%CI 1.27-3.12)。
- 心理健康应答者达到疾病清除的aOR为3.48(95%CI 1.74-7.50)。
关键数值与推荐
- 心理健康应答定义为36项简表调查心理健康子量表评分变化≥7.85。
临床怎么用
- 将心理健康评估整合入溃疡性结肠炎管理策略可能提供超越躯体症状的有价值信息。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Emerging evidence highlight the critical role of mental health in the management of ulcerative colitis (UC). We investigated the relationship between early mental health improvement and long-term disease remission. METHODS: This study used data from the SELECTION trial involving 381 patients treated with filgotinib. Mental health was assessed using the mental health subscale of the 36-item Short-Form Survey. Endoscopic, clinical, and histologic outcomes were assessed at week 58. Adjusted odds ratios (aOR) with 95% confidence intervals (95% CIs) were calculated using multivariable logistic regression. Receiver operating characteristic curves, combined with bootstrap resampling, were used to define the mental health response threshold. RESULTS: Early mental health improvements at week 10 were significantly associated with disease remission at week 58. Patients who showed a mental health response (subscale score changes of ≥7.85) exhibited greater odds of achieving endoscopic remission (aOR 2.67, 95% CI: 1.43-5.25), clinical remission (aOR 1.91, 95% CI: 1.22-2.99), histologic remission (aOR 1.98, 95% CI: 1.27-3.12), and disease clearance (aOR 3.48, 95% CI: 1.74-7.50). In addition, incorporating mental health response assessment along with clinical remission significantly enhanced outcome predictions. Specifically, individuals with only clinical remission at week 10 were approximately half as likely to reach week-58 endoscopic remission (aOR 0.45, 95% CI: 0.21-0.91) compared with those who attained both mental health response and clinical remission. DISCUSSION: Early mental health improvements independently predicted long-term disease remission. Integrating mental health assessments into ulcerative colitis management strategies may provide valuable insights beyond physical symptoms.
引用
- Zheng J, Huang P, Feng R, et al. Early Improvement of Mental Health Is Associated With Long-Term Disease Remission in Ulcerative Colitis. Am J Gastroenterol. 2025. PMID: 40622361. doi:10.14309/ajg.0000000000003638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。